Cargando…
Production, Quality Control and Pharmacokinetic Studies of (166)Ho-EDTMP for Therapeutic Applications
(166)Ho-EDTMP is a major therapeutic agent which is widely used in bone palliation therapy. In this study, a (166)Ho-EDTMP complex was prepared successfully using an in-house synthesized EDTMP ligand and (166)HoCl(3). Ho-166 chloride was obtained by thermal neutron irradiation (1 × 10(13) ncm(−2)s(−...
Autores principales: | Bahrami-Samani, Ali, Bagheri, Reza, Jalilian, Amir R., Shirvani-Arani, Simindokht, Ghannadi-Maragheh, Mohammad, Shamsaee, Mojtaba |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Österreichische Apotheker-Verlagsgesellschaft
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002809/ https://www.ncbi.nlm.nih.gov/pubmed/21179355 http://dx.doi.org/10.3797/scipharm.1004-21 |
Ejemplares similares
-
Production, Quality Control and Pharmacokinetic Studies of (177)Lu-EDTMP for Human Bone Pain Palliation Therapy Trials
por: Bahrami-Samani, Ali, et al.
Publicado: (2012) -
Production, Quality Control and Biological Evaluation of (166)Ho-PDTMP as a Possible Bone Palliation Agent
por: Zolghadri, Samaneh, et al.
Publicado: (2013) -
Production, quality control, and bio-distribution studies of (159)Gd-EDTMP as a palliative agent for bone pain
por: Arani*, Simindokht Shirvani, et al.
Publicado: (2015) -
Production and quality control (177)Lu (NCA)—DOTMP as a potential agent for bone pain palliation
por: Salek, Nafise, et al.
Publicado: (2016) -
Development of (166)Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent
por: Zolghadri, Samaneh, et al.
Publicado: (2014)